Biotech company Alvotech has now moved its shares listed under the ticker symbol “ALVO” from First North Iceland to the Main Market on Nasdaq Iceland.
Since June 2022, shares in Alvotech have been dual-listed on the First North market in Iceland and the Nasdaq Stock Market in the US. The move entails that the company’s share listing has been transferred from First North to the Main Market of Nasdaq Iceland. Alvotech’s shares are now dual-listed on the Nasdaq Iceland Main Market and the Nasdaq US Stock Exchange.
Landsbankinn Corporate Finance managed the process of moving the listing to the Nasdaq Main Market in Iceland.
Our congratulations to the shareholders and employees of Alvotech!